NEJM at ESMO - Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer

N Engl J Med. 2024 Dec 5;391(22):e57. doi: 10.1056/NEJMe2411488. Epub 2024 Sep 15.

No abstract available

Publication types